ClassID:

117126

C12Y305/01015 - CPC Classification

Classification description:

Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1) Aspartoacylase (3.5.1.15)

Recent Application in this class:
#1
20260077060
2026-03-19

Methods of Treating or Preventing Amyotrophic Lateral Sclerosis

#2
20260048146
2026-02-19

METHODS AND COMPOSITIONS FOR TREATING LEUKODYSTROPHIES

#3
20260048104
2026-02-19

METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE

#4
20250255987
2025-08-14

USE OF ENDOGENOUS ASPARTOACYLASE PROMOTER ELEMENTS FOR TISSUE-RESTRICTED EXPRESSION OF GENE THERAPIES

#5
20230332179
2023-10-19

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

#6
20230310652
2023-10-05

VLP FOR THE TREATMENT OF LEUKODYSTROPHIES

#7
20230165977
2023-06-01

MODIFIED NUCLEIC ACIDS ENCODING ASPARTOACYLASE (ASPA) AND VECTOR FOR GENE THERAPY

#8
20220305097
2022-09-29

METABOLIC THERAPY FOR OXIDATIVE STRESS IN THE BRAIN THROUGH TARGETED NEURONAL CATABOLISM OF N-ACETYL-ASPARTIC ACID

#9
20220257731
2022-08-18

METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE

#10
20220098243
2022-03-31

Selective recovery

#11
20210177989
2021-06-17

Methods of Treating or Preventing Amyotrophic Lateral Sclerosis

#12
20200171134
2020-06-04

Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of N-acetyl-aspartic acid

#13
20200087353
2020-03-19

Selective recovery

#14
20190292230
2019-09-26

Selective recovery

#15
20190276849
2019-09-12

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

#16
20190276848
2019-09-12

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

#17
20190194689
2019-06-27

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

#18
20190194688
2019-06-27

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

#19
20190144509
2019-05-16

Selective recovery

#20
20190125899
2019-05-02

Methods and compositions for treating metabolic imbalance

#21
20180311323
2018-11-01

Methods and compositions for treating metabolic imbalance in neurodegenerative disease

#22
20180230186
2018-08-16

Selective recovery

#23
20180148738
2018-05-31

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

#24
20180140687
2018-05-24

Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of N-acetyl-aspartic acid

#25
20170349911
2017-12-07

CNS targeting AAV vectors and methods of use thereof

#26
20170240885
2017-08-24

Selective recovery

#27
20170166926
2017-06-15

Targeting peptides for directing adeno-associated viruses (AAVs)

#28
20150079038
2015-03-19

Recombinant AAV capsid protein

#29
20140335054
2014-11-13

CNS targeting AAV vectors and methods of use thereof

#30
20130323229
2013-12-05

Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of N-acetyl-aspartic acid

#31
20130195801
2013-08-01

CNS targeting AAV vectors and methods of use thereof